Sign In

Glen Reid

Research Fellow at University of Otago

Glen Reid is an Associate Professor in the Department of Pathology at the University of Otago in Dunedin, New Zealand.1 His research focuses on two main areas: understanding drug tolerance in cancer, particularly in melanoma and lung cancer, and translational research into mesothelioma, an asbestos-related cancer.1

Dr. Reid's work on mesothelioma involves studying the role of microRNAs in the biology of malignant pleural mesothelioma (MPM), including biomarker discovery and novel therapeutic approaches.1 This research builds on his previous work in Sydney, which led to the identification of tumor and blood markers and resulted in a phase I clinical trial of microRNA replacement therapy.1

At the University of Otago, Reid is involved in teaching and research student supervision. He lectures for several pathology courses and supervises various student projects, including summer studentships, honors students, and PhD candidates.1

Dr. Reid is a member of several professional organizations, including the International Association for the Study of Lung Cancer (IASLC), the International Mesothelioma Interest Group (iMig), and the New Zealand Society for Oncology (NZSO).1 His research has been published in numerous peer-reviewed journals, with recent publications focusing on topics such as lncRNAs in lung adenocarcinoma, asbestos-related lung cancer, and cell-free DNA methylation in lung cancer management.1

Highlights

Aug 3 · otago.ac.nz
Associate Professor Glen Reid | University of Otago

Related Questions

What are Glen Reid's main research interests?
How is Glen Reid contributing to cancer research?
What are some of Glen Reid's notable publications?
What projects is Glen Reid currently working on?
How does Glen Reid's work impact mesothelioma treatment?
Glen Reid
Glen Reid, photo 1
Glen Reid, photo 2
Add to my network

Location

Greater Sydney Area